William Blair & Company’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,112,140
| Closed | -$3.18M | – | 1896 |
|
|
2024
Q3 | $3.18M | Buy |
1,112,140
+10,815
| +1% | +$30.9K | 0.01% | 603 |
|
|
2024
Q2 | $3.22M | Buy |
1,101,325
+136,273
| +14% | +$398K | 0.01% | 577 |
|
|
2024
Q1 | $3.08M | Buy |
965,052
+282,310
| +41% | +$901K | 0.01% | 580 |
|
|
2023
Q4 | $2.29M | Sell |
682,742
-57,908
| -8% | -$195K | 0.01% | 650 |
|
|
2023
Q3 | $1.76M | Buy |
740,650
+171,910
| +30% | +$409K | 0.01% | 684 |
|
|
2023
Q2 | $1M | Buy |
568,740
+534,397
| +1,556% | +$941K | ﹤0.01% | 840 |
|
|
2023
Q1 | $106K | Buy |
34,343
+15,200
| +79% | +$46.8K | ﹤0.01% | 1495 |
|
|
2022
Q4 | $101K | Buy |
19,143
+1,500
| +9% | +$7.95K | ﹤0.01% | 1489 |
|
|
2022
Q3 | $62K | Sell |
17,643
-30,774
| -64% | -$108K | ﹤0.01% | 1571 |
|
|
2022
Q2 | $125K | Buy |
48,417
+3,200
| +7% | +$8.26K | ﹤0.01% | 1502 |
|
|
2022
Q1 | $203K | Sell |
45,217
-3,746
| -8% | -$16.8K | ﹤0.01% | 1508 |
|
|
2021
Q4 | $333K | Buy |
+48,963
| New | +$333K | ﹤0.01% | 1380 |
|